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Abstract
Saccharomyces cerevisiae has been a powerful model for uncovering the landscape of binary gene interactions through
whole-genome screening. Complex heterozygous interactions are potentially important to human genetic disease as loss-
of-function alleles are common in human genomes. We have been using complex haploinsufficiency (CHI) screening with
the actin gene to identify genes related to actin function and as a model to determine the prevalence of CHI interactions in
eukaryotic genomes. Previous CHI screening between actin and null alleles for non-essential genes uncovered ,240
deleterious CHI interactions. In this report, we have extended CHI screening to null alleles for essential genes by mating a
query strain to sporulations of heterozygous knock-out strains. Using an act1D query, knock-outs of 60 essential genes were
found to be CHI with actin. Enriched in this collection were functional categories found in the previous screen against non-
essential genes, including genes involved in cytoskeleton function and chaperone complexes that fold actin and tubulin.
Novel to this screen was the identification of genes for components of the TFIID transcription complex and for the
proteasome. We investigated a potential role for the proteasome in regulating the actin cytoskeleton and found that the
proteasome physically associates with actin filaments in vitro and that some conditional mutations in proteasome genes
have gross defects in actin organization. Whole-genome screening with actin as a query has confirmed that CHI interactions
are important phenotypic drivers. Furthermore, CHI screening is another genetic tool to uncover novel functional
connections. Here we report a previously unappreciated role for the proteasome in affecting actin organization and
function.
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Introduction
There has been an increasing interest in multi-genic influences
on human disease, perhaps in part because most genetic disorders
with simple, monogenic origins have been described but also
because some very prevalent and devastating diseases, such as
cancer and psychiatric disorders, are now recognized to have
complex genetic influences [1]. Extensive efforts are being made to
identify the genes involved in complex genetic disorders, but this
frequently amounts to trying to find a needle in a haystack of
genetic diversity. An admittedly large chasm exists between these
top-down approaches (disease-to-gene) and the bottom-up ap-
proaches (gene-to-phenotype) being leveraged in model systems,
but an argument can be made that the bottom-up approaches are
having a broader impact in how we think about genome dynamics
and hold the promise for identifying conserved genetic vulnera-
bilities. For example, the large datasets generated by yeast
genomic and proteomic approaches have been critical to the field
of network biology and have helped lead to an understanding of
system robustness, interconnectedness and the evolutionarily
conserved aspects of biological networks [2]. The relatively high
number of connections between genes and proteins in yeast
biological networks suggests that systems can often adjust to the
loss of a single component, a prediction that is born out by the
simple observation that most yeast genes (,5,000 out of ,6,000)
are not essential [3]. Secondly, yeast networks show short path
lengths between all genes/proteins in the network, indicating a
high level of interconnectedness between cellular functions [4].
Clearly the greatest contributions to understanding genetic
interaction networks has come from the labs of Charles Boone
and colleagues in their efforts to define the entire constellation of
binary synthetic lethal interactions by synthetic genetic array
(SGA) analysis in Saccharomyces cerevisiae. Besides contributing to our
understanding of biological network topology, the extensive
amount of genetic interaction data generated by SGA synthetic
lethal screening has allowed for understanding epistatic relation-
ships and how they can be interpreted to infer functional
relatedness, and in particular whether sets of genes function in
the same, parallel, or unrelated pathways [4–5].
Our lab has more recently become interested in digenic
influences on phenotype, specifically in diploid cells and
organisms. Our approach is distinguished from that of SGA
analysis because it allows for complications resulting from
heterozygosity at two loci. Specifically, we examine the phenotypic
consequences of being hemizygous (one loss of function allele/one
wild type allele) at two loci; if the negative consequence is greater
than that expected based on single hemizygosity, we define the
gene pair as displaying a complex haploinsufficient interaction
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suggests to us that CHI interactions may be very important
phenotypic drivers and contributors to genetic disorders in human
populations. The 1000 Genomes Project Consortium recently
published the results from whole-genome sequencing of 179
individuals and remarkably discovered that on average, human
individuals inherit 250–300 loss-of-function alleles [6]. This is a
strikingly high number in comparison to previous estimates and
suggests that every person inherits a unique combination of over
44,000 potentially deleterious CHI gene pairs (300-choose-two is a
binomial coefficient determined by the factorial equation N!/
K!(N-K)! where N is the number of elements and K the subsets of
N). A critically important question is how many complex
hemizygosities are deleterious. We previously addressed this
question using the yeast model and a null allele of the essential
actin gene to screen for CHI interactions with the ,4,800 non-
essential gene knock-out alleles. We have found that null alleles for
,240 non-essential yeast genes display deleterious CHI interac-
tions with the actin null allele ([7]. Although we admit that actin is
a particularly important and multi-functional gene, these results
strongly argue that the landscape of potentially deleterious CHI
interactions is likely to be quite large.
As has been observed in the synthetic lethal data, our network of
CHI genes is highly enriched for certain functional groups
including several functions and complexes known to be involved
in actin function. In addition, we uncovered unanticipated genetic
vulnerabilities reflecting novel connections to the actin cytoskel-
eton that were not predicted by more traditional approaches such
as protein interaction studies [7]. What this suggests to us is that
efforts to map the causes of multi-genic human disorders is going
to continue to be problematic as it may be difficult to predict
which genes neighboring a chromosomal region linked to disease
inheritance are responsible for the phenotype of interest. This is
likely to be made even more complicated by the influences of
several hundred additional loss-of-function alleles. We argue that
knowing the landscape of binary CHI gene interactions in a simple
eukaryotic may be very useful in predicting multi-genic influences
in human genetic disorders, in particular when the affected genes
disrupt core cellular functions. At this time we do not have clear
examples of CHI interactions causing human disease. However,
single gene haploinsufficiencies in 32 different transcription factors
causes a diverse array of human genetic disorders [8], haploin-
sufficiency of 23 different tumor suppressor genes has been shown
to contribute to tumorigenesis [9], and complex haploinsufficiency
has been shown in mouse models to contribute to early aging [10]
and tumorigenesis [11–12]. We suspect that examples of CHI
interactions in humans are lacking due to the difficulties associated
with detecting these interactions and not because they aren’t
consequential.
Since our first CHI screens were performed on the non-essential
gene set, many core and conserved cellular processes that are
facilitated largely by essential genes were missed. Here we report
an adaptation of this approach that enables the analysis of
complex heterozygous combinations of essential gene deletions
and its use to expand the actin CHI network to include 60 essential
genes. There is extremely significant functional enrichment in the
actin CHI essential gene network, including the inclusion of many
genes for proteasome components. The proteasome is known for
its ability to degrade ubiquitinated proteins. However, our
preliminary analysis of its role in actin regulation suggests it may
play a structural role in the actin cytoskeleton.
Results
A novel screen for the identification of complex
haploinsufficient interactions between an actin null allele
and null alleles of the essential genes of yeast
In a previous report [7], we presented a genome-wide analysis
of complex haploinsufficiency (CHI) interactions arising in diploid
strains deleted for one copy of the unique and essential actin gene
(ACT1) and for one copy of a non-essential gene. This was
performed by mating a haploid strain deleted for ACT1 (kept alive
by a counter-selectable ACT1-containing plasmid) with the
EuroScarf haploid non-essential gene deletion mutant array.
Diploids that were impaired for growth without the ACT1 plasmid
indicated that the double hemizygosity was incapable of
supporting (robust) growth. While we have uncovered ,240 such
detrimental combinations ([7]; and Haarer, Viggiano and
Amberg, unpublished), an argument can be made that perhaps
more relevant or stronger CHI interactions might occur when both
hemizygous mutations are in essential genes. Furthermore, many
fundamental processes are executed by essential genes and these
would have been missed by the previous screening method.
In order to carry out a similar screen against essential genes, we
took advantage of the observation that spores carrying deletions of
many essential genes are still competent to mate prior to dying
[13], presumably due to a sufficient complement of maternal
factors to support germination and limited growth. Therefore, we
first sporulated the hemizygous diploids from the EuroScarf
(http://web.uni-frankfurt.de/fb15/mikro/euroscarf/) collection
of S. cerevisiae strains deleted for essential genes. These spores
were then directly mated to our act1D query strain (carrying ACT1
on a counter-selectable plasmid) and diploids carrying both the
Nat
R-marked act1D allele and G418
R-marked gene deletions were
selected and analyzed for growth defects on medium that selected
for cells that had lost the ACT1-bearing plasmid. In this manner
we were able to perform complex haploinsufficiency screens
against these essential genes.
As with CHI screening against non-essential genes [7], our
essentials-only CHI screens generated substantial numbers of
interactions that varied in severity from lethal to moderately slow
growing. Overlap between screens varied, ranging from 11 to
49%. From four separate screens against the EuroScarf collection
Author Summary
Individuals inherit two copies of each gene, one from each
parent, and frequently the two copies are different from
each other. Sometimes one copy is completely defective,
but since there is one normal copy there may be no
negative consequences. Our research is focused on
understanding the consequence of inheriting one bad
copy for two or more different genes. Geneticists refer to
inheriting one bad copy of a gene as a haploinsufficiency
and inheriting one bad copy of multiple genes as a
complex haploinsufficiency. Using yeast as a model
system, we have addressed, in a systematic way, what
occurs if a cell inherits one bad copy of the gene called
actin and one bad copy of one of the ,1,000 essential
genes in the yeast genome. We discovered that complex
haploinsufficiency between actin and one of 60 different
essential genes leads to reduced cell viability. These 60
genes are highly enriched for certain functional groups,
including those involved in protein degradation and gene
expression. It is expected that approaches such as these in
model organisms will be applicable to understanding the
potential for deleterious complex haploinsufficient inter-
actions in the human genome.
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potential CHI interactions, of which 39 were hit twice, 14 were hit
three times, and 6 were hit in all four screens.
We have previously found that screening robotically results in a
large number of false positives necessitating manual confirmation
or ‘‘hand testing’’ which involves manually mating the strains on
plates and streaking for single colonies on selective plates. This
allows us to examine the growth characteristics of several clonal
isolates for each CHI cross. Hand retesting of the 212 potential
CHI interactions allowed us to confirm 48 authentic act1D CHI
interactions; the other 164 failed to confirm by the more rigorous
hand tests and are therefore false positives. From the primary
screen data, we identified related functional groups (see below) that
implicated another 24 genes; of these, 12 of the genes’ null alleles
tested positive for a CHI interaction in subsequent hand tests. This
combined network of 60 genes is shown in Figure 1; note that the
color coding reflects the major functional gene ontology terms
assigned to the genes as indicated in the key. This number of
interactions is probably underestimated, as we continue to see
some variability or ‘‘escape’’ from the FOA screen (see below and
Figure 2A). We believe that escape can occur through multiple
mechanisms, including conversion or duplication at either mutant
locus, mutational inactivation of the plasmid-borne URA3 marker,
or chromosome non-disjunction leading to trisomies for either the
chromosome bearing the CHI gene or a chromosome for some
other gene capable of suppressing the CHI interaction. We believe
the latter is most likely, as the reported frequency of spontaneous
aneuploidies in S. cerevsiae is as high as 1610
24 [14–15]. Notably,
the number of confirmed hits for both the essential and non-
essential deletion collections is ,5% of the total number of genes
represented in each collection, which would seem to suggest that
the essential genes are no more predisposed to CHI interactions
than are the non-essential genes. However, it may be that that the
false negative rate is higher for the essential gene screens possibly
as a result of the sporulation step; if this is true then essential genes
may, on average, have more CHI interactions than non-essential
genes as has been observed for synthetic lethal screens.
Phenotypic analysis of CHI strains
To obtain a more quantitative measure of CHI interactions, we
sought to determine growth rates of double hemizygotes upon loss
of the ACT1 plasmid. For this purpose we adopted a small-scale
liquid media approach and utilized a TECAN microplate reader/
shaking incubator. Several notable observations were made while
carrying out these liquid media growth tests: 1) The restrictive
temperature for actin hemizygotes is significantly lower in liquid
media. While 34–35u (our typical ‘‘high temperature’’ CHI
screening mark) is permissive for growth of ACT1/act1D strains
Figure 1. Network of CHI interactions between act1D and null alleles for essential genes. Where applicable, genes are grouped into
functional categories; color-coding of major GO terms is as indicated in the key. The interaction network was generated using the program Osprey
[46]. EHD, essential heterozygous diploid.
doi:10.1371/journal.pgen.1002288.g001
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impaired for such strains in liquid media. 2) Only the strongest
CHI hits (generally scored as 1=inviable or 2=severe growth
defects) exhibited detectably reduced growth rates by this method
(see Figure 2B). Presumably, expansion of the CHI culture allows
for greater opportunities for suppression events caused by genetic
instability such as the generation of trisomies by chromosome non-
disjunction. As mentioned above, even for the strongest CHI
interactions, such as the interaction with tub1D, escape events are
not infrequent. This can be seen fairly clearly in Figure 2A where
the ACT1/act1D tub1D/TUB1 complex hemizygote culture traced
with yellow triangles had an escape event while the culture traced
in red squares did not. Interestingly, the liquid growth behavior of
CHI strains manifested as delays in the onset of logarithmic
growth and/or differences in the slopes during logarithmic growth
(see Figure 2A and 2B). For the strongest CHI interactions, such as
with tub1D and taf5D, long delays are followed by low slopes in the
growth curve. For CHI interactions of more modest strength, such
as with pfy1D, cct4D, and arc19D, modest delays are followed by
fairly small differences in slope from the control cultures.
Curiously, the rpn6D culture shows a delay over the control
culture but no difference in slope once log-phase growth is entered
(Figure 2B). Although it is difficult to obtain a strict quantitative
measurement of a CHI interaction using TECAN growth curve
analysis, it does provide another means to compare the strengths
of the interactions over mere colony size.
A normal wild type cell typically has 4–5 actin cables that run
along the long axis of the cell, terminating at the bud neck or
extending into the bud. Actin cables are used by myosin motors to
facilitate the polarized transport of materials into the bud. The
other prominent actin structures are actin cortical patches, which
in a wild type cell are polarized in the bud for most of the cell cycle
and become polarized to the bud neck near the end of the cell
cycle. Actin cortical patches are sites of endocytosis. For an
example of normal actin organization, see ‘‘WT’’ in Figure 5C.
Actin-specific phenotypes are relatively normal for most hemizy-
gotes of the act1 CHI set (data not shown). We had previously
reported that the non-essential genes whose null alleles are CHI
Figure 2. Growth curves of doubly hemizygous strains. A TECAN shaking incubator/microplate reader was used to follow growth of the
indicated complex hemizygotes (with ACT1/act1D::Nat
R)i nS C
msg+G418+Nat media without (control) or with FOA. Panels (A) and (B) are from
independent experiments.
doi:10.1371/journal.pgen.1002288.g002
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defects as haploids [7]. A comparable analysis cannot be
performed with the essential gene null alleles that are CHI with
actin, instead we examined the actin cytoskeleton in some of the
complex hemizygotes. This analysis was complicated by the fairly
severe actin organization defects in the act1 hemizygote alone,
which has abundant but depolarized actin cortical patches and
poor actin cable formation and polarization (see Figure 3B). We
did note some actin and morphological defects beyond those of the
act1 hemizygote (Figure 3A) in several complex hemizygotes,
including those carrying pfy1 (Figure 3B), rpn5 (Figure 3C), and
tub1 (Figure 3D), while others had few, if any, additional defects.
Lowering actin levels appears to affect actin cable formation more
seriously suggesting that the patch F-actin nucleation machinery
(the Arp2/3 complex) is less sensitive to low actin concentrations
than the cable nucleation machinery (the formins). The larger,
rounder cells of the act1/ACT1
wt pfy1D/PFY1
wt complex hemizy-
gote and extreme patch depolarization (Figure 3B) are reminiscent
of various pfy1 point mutants and represent a much less severe
phenotype than that of barely viable pfy1D haploid cells [14].
Many of the complex hemizygotes with deletions of proteosome
component genes showed an elongated cell and bud phenotype, an
example of which is shown for rpn5 in Figure 3C. The ACT1/act1
tub1/TUB1 hemizygotes displayed severe and heterogeneous
defects in actin organization and cell morphology. In many cases
actin assembly was overly elaborate and completely polarized in
Figure 3. Actin staining of complex hemizygotes. ACT1/act1D::Nat
R hemizygotes carrying additional hemizygous mutations for (A)
yal066wD::kan
R (control gene deletion), (B) pfy1D::kan
R, (C) rpn5D::kan
R, and (D) tub1D::kan
R were fixed and stained with rhodamine phalloidin after
growth at 30u in YPD medium.
doi:10.1371/journal.pgen.1002288.g003
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observation that stabilization of filamentous actin is detrimental
when actin is limiting [7].
Functional enrichment in the essential genes that are CHI
with act1D
As in our previous study [7], we noted that several genes whose
null alleles are CHI with act1D express proteins that fall into
common pathways or complexes. Hand testing of strains bearing
null alleles for other (previously not hit) members of these
pathways or complexes resulted in the identification of 12
additional CHI interactions with act1D. This observation alone
argues that there is functional enrichment in the network. Some
functional overlap was observed between this and our previous
screens of the non-essential knock-outs. For example, here we
found interactions with null alleles for two essential components of
the Arp2/3 complex (ARP3 and ARC19) and a null allele for the
Arp2/3 activator LAS17. We also found an interaction with a null
allele for one of the few (nearly) essential actin binding protein
genes (yeast profilin; PFY1), and we found interactions with null
alleles for two genes for the essential Tcp1p chaperone complex,
which helps to fold actin and tubulin subunits; the previous screen
saw interactions with null alleles for several components of the
separate and non-essential prefoldin chaperone complex that also
helps to fold both actin and tubulin subunits [15].
Our original CHI screen against the non-essential genes missed
many cellular functions that are executed by essential genes.
Although the screens against the non-essential knock-outs
identified many genes involved in endocytic processes, most of
the exocytic genes that had been frequently found in previous
classical genetic screens with actin (e.g. suppression screens; [16])
were missed because these are almost entirely essential. Here we
saw an interaction with the null allele for the late secretory vesicle
small GTPase Sec4 and null alleles of genes for two components of
the coatamer complex (RET2 and COP1) that facilitate retrograde
transport from the golgi to the ER. Also notable are the
interactions with the tubulin cytoskeleton, in particular tub1D
whose wild type allele encodes for alpha-tubulin, tub4D whose wild
type allele codes for gamma-tubulin that nucleates microtubules at
the spindle pole body, and spc42D whose wild type allele codes for
a core component of the outer plaque of the spindle pole body.
Since actin has been shown to be involved in nuclear positioning
and segregation during mitosis ([17] and references cited within)
the interactions with tubulin and spindle pole body genes may
reflect catastrophic defects in nuclear positioning under conditions
of limiting actin concentration. Statistical analysis does confirm
that the network is enriched for genes annotated to the GO
component term ‘‘cytoskeleton’’ with a p value=6.62610
213.
This includes the genes: PFY1, TUB1, LAS17, CCT4, TUB4,
ARC19, SPC42, SEC4, CCT8, and ARP3 [18].
Most striking were the extensive interactions with null alleles of
genes for the TFIID complex and the proteasome. Knock-out
alleles of nearly all of the TAFs that make up the proteins of the
TFIID complex were found to be CHI with act1D; statistical
analysis for GO-term enrichment gave a p-value of 1610
214 for
the GO Biological Process term ‘‘transcriptional pre-initiation
complex assembly’’ [19]. This could be the result of poor
expression of actin and/or actin binding proteins, a hypothesis
that is supported by CHI interactions between act1D and deletion
alleles for three components of the RNA polymerase II complex
(RPB7, RPB3, and RPC10). However, since actin has been found to
be a core component of the RNA polymerase II pre-initiation
complex [20] and to be involved in transcriptional elongation [21],
these interactions may reflect a more direct role of actin in
transcription. For example, stoichiometry suggests that actin in the
RNA polymerase II complex is in the monomer form [19] and we
have shown that the actin hemizygote is particularly limited for G-
actin [7].
Particularly surprising are the extensive CHI interactions with
null alleles for genes of the proteasome. Of the 33 genes that
encode for all components of the 26S proteasome, we found that
the knock-outs for 15 were CHI with act1D. The p-value for
enrichment of the GO biological process term ‘‘ubiquitin-
dependent protein catabolic process’’ is a remarkable
6.5610
213. The genetic interaction between actin and proteasome
genes could also be the result of indirect effects such as alterations
in the protein levels of actin or key actin regulators. We have not
performed an extensive analysis of the levels of all actin regulators
but have looked at actin itself and its levels are unchanged in
proteasome mutants. Alternatively, it could reflect a direct role of
the proteasome in the regulation of the actin cytoskeleton or vice
versa.
Null alleles for subsets of proteasome component genes
are CHI with act1D
The proteasome is a large macro-molecular complex that
executes much of the protein degradation activity of the eukaryotic
cell (see Figure 4). It consists of a 20S core particle (CP) that is
capped at one or both ends by a 19S regulatory particle (RP; see
Figure 4A). The CP consists of two central, heptameric ß-rings
composed of 7 different ß-subunits that are sandwiched between
two a-rings similarly composed of 7 a-subunits. The CP contains
the proteolytic sites while the RP is involved in substrate
recognition and protein unfolding. The RP can be further
subdivided into a lid complex that is coupled to the base complex
by the Rpn10 protein [22]. Interestingly, nearly all proteasome
components (with the exception of the a-3 subunit Pre9p and the
cap coupling subunit Rpn10p) are essential and presumably
required for proteasome activity, and yet not all knock-outs of
proteasome component genes display a CHI interaction with act1D
(see Figure 4A). Concerning the RP, we observed that null alleles
for all genes of the lid complex components except SEM1 were
CHI with act1D. In contrast, a knock-out for only one gene (RPT2)
of the base complex was CHI with act1D and a null allele for the
Rpn10p linker was also not CHI with act1D. With respect to the
20S core, we observed that null alleles for only three of the alpha
subunit genes (PRE5, PRE10, and SCL1) and three of the ß-subunit
genes (PUP1, PRE1, and PRE2) were CHI with act1D. Note that
three ß-subunit genes encode for the three proteolytic activities of
the proteasome and two of the three are CHI with actin; PUP1
encodes for the subunit with trypsin-like activity and PRE2
encodes for the chymotryptic activity [23–24]. Interestingly, only
the chymotryptic activity of the proteasome is essential [24].
The crystal structure of the proteasome 20S core indicates that
each of the alpha and beta subunits occupies distinct locations
within the two a– and ß-rings [25]. Figure 4B and 4C shows
surface renderings of the structure of the 20S proteasome core
with the CHI components colored and labeled. Strikingly, the a-
ring CHI subunits are adjacent to each other and generally do not
overlap with the ß-ring CHI subunits, such that a- and ß-subunits
lie on opposite surfaces of the barrel-shaped core. The asymmetry
of CHI interactions for proteasome subunit genes could reflect that
these components are limiting and that reductions in their levels
leads to defects in proteasome assembly. For example, the
juxtaposition of CHI and non-CHI subunits in the 20S core
particle may reflect the roles of co-templated interactions between
subunits of the a- and ß-rings during the assembly of the
intermediate, 20S CP K ring complex [26].
Complex Haploinsufficiency Screening with Actin
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To examine if there may be a functional connection between
the proteasome and actin, we obtained several Ts
2 alleles of
proteasome component genes ([27] and gift of C. Boone) and
examined their growth characteristics on both plate media and in
liquid cultures after a shift to 37uC. We noted that the proteasome
mutants varied in their extent of growth defects at 37uC.
Interestingly, some proteasome mutants failed to form colonies
at 37uC but appeared to grow relatively normally in liquid cultures
at 37uC. Typically we have observed that strains with Ts
2 alleles
tend to behave similarly on both plate and in liquid cultures (with
the exception of the ACT1 hemizygote) and so the discrepancies
observed for proteasome mutants may reflect something special
about these genes or the proteasome in general. The growth
behavior of the proteasome mutants is noted in Table 2.
To examine the actin cytoskeleton in proteasome mutants, we
stained log-phase cultures of proteasome mutant strains with
rhodamine-phalloidin following a 2 hr shift to 37uC and examined
actin organization by fluorescence microscopy. Interestingly, there
was a wide range of phenotypes observed, from completely wild
type actin organization to very severe defects in actin organization
(see summary in Table 2 and examples of actin staining in
Figure 5B). We scored a mutant as having severe defects when
virtually all the cells in the culture were mutant: generally very
large cells usually lacking cables and with numerous depolarized
patches. Moderate defects indicate cultures in which most of the
cells have morphology defects, generally large and sometimes
hyper-elongated cells with excessive cables. Actin defects did not
strictly correlate with whether the null allele for the proteasome
mutant is CHI with actin, whether the subunit it encodes is in a
particular sub-complex of the proteasome, or the extent of
temperature sensitivity of the mutant strain. In Figure 5 we
highlight the results from a set of mutants that have largely
equivalent Ts
2 phenotypes in liquid culture as shown by growth
curves generated using a TECAN microplate reader (Figure 5A).
This included alleles for three lid complex genes (rpn5-1, rpn11-14,
and rpn12-1) and alleles for two base complex genes (rpn1-821 and
rpt1-1). As can be seen in Figure 5B, the three lid complex mutants
have severe actin and cell morphology defects that are notable at
permissive temperature (25uC) and get even worse at 37uC. At
25uC the cells are large, frequently elongated with elongated buds,
the actin cortical patches are well polarized, and the actin cables
are present and polarized. At 37uC, the cells became extremely
large with depolarized cortical patches and if actin cables are
present they are largely disorganized. This phenotype was typical
for those proteasome mutants that display actin organization
defects and although these strains are presumably arresting their
growth due to defects in proteolysis, the actin defects alone are
severe enough to possibly cause inviability. In stark contrast, the
rpn1-821 and rpt1-1 mutant cells were completely normal for both
cell morphology and actin organization at both 25uC and 37uC
(Figure 5C). The kinetics of growth arrest at 37uC for all strains
was similar and yet only some of the mutants arrest with actin
defects. Although we do not know the reasons for this phenotypic
variation, we suspect it may relate to differences in how the
mutants affect proteasome assembly and function, in particular a
possible actin specific function.
The proteasome inhibitor MG132 elicits distinct defects
in cell morphology and actin organization
The actin organization defects observed in the rpn5, rpn11, and
rpn12 Ts
2 strains (and others) were expected to be attributable to
loss of proteolysis activity of the proteasome complex. The
Figure 4. The structure of the proteasome and the locations of subunits whose null alleles are CHI with act1D. (A) Cartoon of the
structure of the 26S, doubly capped proteasome showing the general locations of subunits whose null alleles are CHI (bold and underlined) or are not
CHI with act1D; based on cryo-EM reconstructions of the 26S proteasome [47]. (B) and (C) Surface rendering of the 20S core proteasome X-ray
structure (1RYP.pdb; [25]); panels are rotated 180u with respect to each other. Proteins whose null alleles are CHI with act1D have been rendered in
color: red for Scl1p, gold for Pre10p, orange for Pre5p, teal for Pup1p, light blue for Pre1p, and dark blue for Pre2p. Rendering was performed with
Chimera (http://www.cgl.ucsf.edu/chimera).
doi:10.1371/journal.pgen.1002288.g004
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inhibitor that covalently modifies the active site threonine of the
chymotryptic center of the Pre2p subunit [25–26,28]. Although
MG132 specifically targets the chymotryptic activity of the
proteasome, it significantly reduces the proteolytic activity of the
other two ß-subunits as well [28]. This and related derivatives have
been used extensively to study mammalian cell proteasome
function but its utility in studying yeast proteasome function is
limited by cell permeability issues. However, an ergosterol
biosynthesis mutant (erg6) has been shown to increase cell
permeability to a number of drugs, in particular an erg6 mutation
has been shown to render yeast cells sensitive to MG132 [29]. We
grew an erg6D strain to mid-log, treated it +/2100 mM MG132 for
2 hr and stained the actin cytoskeleton with rhodamine-phalloidin.
A comparable treatment of an erg6 mutant strain had previously
been show to cause an ,80% inhibition of in vivo proteasome
activity [29]. Despite an assumed comparable inhibition in our
hands, we saw absolutely no effect of MG132 treatment on actin
organization (Figure 6A). Deletion of the gene for the ABC, multi-
drug transporter Pdr5p has also been shown to render yeast cells
sensitive to 50 mM MG132 [30]. However, as similarly observed
for the erg6D strain, treatment of a pdr5D strain with 100 mM
MG132 for 2 hr had no effect on actin organization (Figure 6A).
To confirm that the MG132 was in fact inhibiting the proteasome,
we isolated proteins from cells treated with 50 mM MG132,
separated the protein samples by SDS-PAGE and Western blotted
with anti-ubiquitin antibodies (Figure 6B). Both the erg6D and
pdr5D cells as well as the wild-type control accumulated
ubiquitinated proteins during the 2 hr treatment with MG132.
However, we noted that both erg6D and pdr5D strains continue to
grow in the presence of 100 mM MG132 (see Figure 7A; GAC201
is a pdr5D strain) indicating that the residual activity of uninhibited
proteasomes is sufficient to maintain cell growth and viability
despite the accumulation of significantly high levels of ubiquiti-
nated proteins.
It has been shown that yeast can survive without the trypsin-like
activity of Pup1p and the caspase-like activity of Pre3p [23]. More
recently a strain was developed in which the active site threonines
of both Pup1p and Pre3p were mutated, rendering the strain
completely reliant on the chymotrypsin activity of the Pre2p
subunit. This strain also carries a pdr5D allele, rendering it
completely sensitive to MG132 for cell growth and viability [31].
We confirmed the sensitivity of this strain to MG132 by
performing TECAN growth curves (Figure 7A), note that the
hyper-sensitized GAC202 strain arrests growth immediately
following the addition of MG132 (Time 0). We treated this strain,
and a control strain bearing wild type alleles of PUP1 and PRE3,
+/2100 mM MG132 for 2 hr followed by rhodamine-phalloidin
staining to visualize the actin cytoskeleton (Figure 7B). Strikingly,
the MG132 sensitive strain treated with MG132 displayed a high
percentage of cells with F-actin accumulation at the tips of long
and narrow buds. We quantified the percentages of cells with these
hyper-elongated buds and found that in cultures of the MG132-
sensitive strain grown in MG132, nearly 20% of the cells displayed
this phenotype as compared to at most 3% in control cultures (see
Table 3). Since the control strains carry plasmids encoding the
wild type copies of PUP1 and PRE3, we assume the low percentage
of cells with elongated buds observed in the MG132-treated
control strain are the result of plasmid loss. Interestingly, this
elongated bud phenotype is distinct from that observed in
proteasome subunit Ts
2 strains (see Figure 5B). Elongated buds
are observed in some Ts
2 proteasome mutants but they tend to be
broader, particularly in the neck region. The overwhelmingly
common phenotype at 37uC, for proteasome mutants that do
show actin defects, is large cells with a depolarized actin
cytoskeleton. In contrast, the arrest phenotype observed in the
MG132 hypersensitive strain is actin hyper-polarization and is
more reminiscent of a cell cycle defect, likely reflecting the well-
established role of the proteasome in degradation of cell cycle
regulators [32].
Both the 19S regulatory and the 20S catalytic particles of
the proteasome precipitate in association with actin
filaments
The diversity of actin organization defects observed in some
proteasome mutants suggested that perhaps the proteasome could
be regulating actin via a direct interaction. To test this possibility,
we purified assembly competent actin and the 19S proteasome RP
from yeast. Actin filament pelleting assays were used to assay for
19S RP association specifically with actin filaments. When the
actin is kept in the monomeric form by incubating in low salt G-
buffer and submitted to high-speed centrifugation at 190,0006g,
Figure 5. Growth and actin organization defects in conditional
mutants of proteasome components. (A) Growth of strains
carrying temperature sensitive alleles of proteasome genes were
monitored and compared to the growth of a wild-type strain
(BY4741) in a TECAN microplate reader at 37uC for 24 hr. (B and C)
Strains carrying Ts
2 alleles in proteasome component genes were
grown to mid-log, shifted to 37uC for 2 hr, fixed, stained with
rhodamine phalloidin and visualized by fluorescence microscopy. (B)
Proteasome mutant strains with actin organization defects. (C)
Proteasome mutant strains that do not have actin organization defects.
doi:10.1371/journal.pgen.1002288.g005
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When the actin was incubated in the presence of ,65 nM yeast
19S RP, the actin remained in the supernatant in G-buffer and
none of the 19S RP was found in the pellet fraction (Figure 8A).
However, when actin polymerization was stimulated with salt and
magnesium in F-buffer, most of the actin is found in the pellet
phase (see Figure 8B) and most of the 19S RP proteins pellet with
the actin filaments. Note that the 19S RP is not found in the
supernatant fraction as this fraction is taken from the very top of
the reaction; we have sampled down the column of F-buffer
centrifugation reactions and consistently find that the 19S RP
migrates to a fraction above the pellet (data not shown). To
confirm the apparent association of the 19S RP with actin
filaments, we analyzed both the 19S preparation and the F-actin
plus 19S pellet by mass-spectrometry, specifically reverse phase
chromatography in line with tandem MS using an LTQ Orbitrap
XL. The 19S prep was confirmed to contain multiple high
confidence peptides for all of the lid and base components, for the
Rpn10p linker, and for the Rpn14p proteasome assembly factor.
In the F-actin plus 19S pellet a large number of actin peptides
were identified, multiple peptides for all 9 base components,
multiple peptides for 7 of 8 lid components but only 1 peptide for
lid component Rpn5p (data not shown). It is likely that the large
concentration of actin peptides in the pellet fraction obscured the
identification of some 19S RP peptides. Regardless, the mass-
spectrometry results provide strong support for the physical
association of the full 19S RP with actin filaments in our pelleting
assays.
To examine for a potential association between the 20S core
proteasome and F-actin, pelleting assays were repeated with
preparations of 20S core purified from a strain expressing Flag-
tagged Pre1p [33]. As was observed for the 19S RP (Figure 8A),
when the actin was incubated in the presence of 50–100 nM yeast
20S proteasome, the actin remains in the supernatant fraction
(Figure 8C). When actin polymerization was stimulated in F-
buffer, most of the 20S CP proteins pelleted with the actin
filaments (see Figure 8D). Sampling of the entire fractionation
consistently showed that the 20S proteasome, like the 19S RP,
migrated to a fraction above the pellet (data not shown). The
strong association of the 19S RP with F-actin suggests that 19S RP
Figure 6. Cells treated with the proteasome inhibitor MG132 have normal actin cytoskeleton organization. (A) To facilitate drug
permeability or accumulation, erg6D and pdr5D strains were grown to mid-log, treated with 100 mM MG132 for 2 hr, fixed, stained with rhodamine
phalloidin and visualized by fluorescence microscopy. (B) Wild-type (BY4742), erg6D, and pdr5D cells were treated with 50 mM MG132 and protein
samples were isolated 0, 30, 75, and 120 min after MG132 addition to the medium. Protein concentrations were determined by Bradford assays and
,45 mg of protein were separated by SDS-PAGE and analyzed by Western blotting with an anti-ubiquitin antibody.
doi:10.1371/journal.pgen.1002288.g006
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association. To determine if 19S RP is present in the 20S preps, we
performed the mass-spec analysis of the 20S preps and did find
that the 20S preparation is contaminated with 19S RP proteins.
However, the converse was not true; no 20S contamination was
found in the 19S preparations (data not shown).
Discussion
Although DNA replication and repair occur with impressive
fidelity, the sheer amount of information that must be copied
ensures that every time a genome is replicated, heritable mistakes
are made. Over time, these errors and larger scale changes in
chromosomes such as transposon movement, repeat expansion
and contraction, and chromosome rearrangements have led to
significant genetic diversity in populations. These genetic alter-
ations have resulted in complex heterozygosity at many loci that
are re-assorted every generation, resulting in a moving target of
complex genetic interactions whose influence on phenotype is
difficult to ascertain. Many, but not all, mutations are silent but it
has been estimated from deep sequencing of 179 human
individuals, that we all inherit 250–300 loss-of-functional alleles.
Cancer cells represent perhaps the most extreme case of genetic
diversity, as they frequently lose whole chromosomes or whole
sections of chromosomes, resulting in the potential for thousands
of complex haploinsufficient interactions. In our work we have
been attempting to model CHI interactions in a simple eukaryote
and specifically using the single essential actin gene, which plays
critical roles in a large number of cellular functions. Our results
confirm that there is a tremendous potential for deleterious CHI
interactions in the genome. However, actin is so centrally
important, we cannot say that all genes will be so genetically
promiscuous.
Genetic interaction analysis has been used extensively in yeast to
attempt to identify functionally related genes, the well supported
assumption of course being that a binary gene interaction suggests
relatedness. Such screens have led to a fairly anecdotal lore about
what a particular type of interaction means, e.g. suppressor screens
tend to identify gene products that physically interact or at least
operate in the same pathway. The tremendous amount of
synthetic lethal data generated by the Boone laboratory has
pushed the ability to formalize rules about synthetic lethal
interactions and how patterns of such interactions can be
accurately used to determine function in same or parallel pathways
Figure 7. Complete inhibition of the proteasome induces a hypolarization phenotype. (A) A pdr5D/PUP1
WT/PRE3
WT/PRE2
WT (GAC201) and
a pdr5D/pup1
T30A/pre3
T20A/PRE2
WT (GAC202) strain were grown into mid-log phase, treated with DMSO, 50 mM, or 100 mM MG132 and their growth
was monitored in a TECAN microplate reader at 30uC. (B) The GAC201 and GAC202 strains were grown into mid-log phase, treated with 100 mM
MG132 (or with a comparable amount of the DMSO solvent) for 2 hr, fixed with formaldehyde, stained with rhodamine-phalloidin and visualized by
fluorescence microscopy.
doi:10.1371/journal.pgen.1002288.g007
Figure 8. Both the proteasome 19S regulatory particle and 20S core particle associate with actin filaments. 4 mM yeast actin and either
,65 nM 19S proteasome regulatory particle (A and B) or 50–100 nM 20S proteasome core particle (C and D) were incubated in G-buffer (A and C) or
in F-buffer (C and D), centrifuged at 190,0006g and volume-corrected samples were taken from the supernatant (S) or pellet (P) phases. T are the
fractions taken prior to centrifugation. All fractions were separated by SDS-PAGE and stained with SYPRO Ruby (Bio-Rad, Hercules CA).
doi:10.1371/journal.pgen.1002288.g008
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time, we expect that many of the lessons learned from synthetic
lethality will hold true.
It is not surprising that a null allele for actin would have such a
large number of CHI interactions; the actin cytoskeleton is
centrally important to many cellular functions. Further, actin can
exist in many highly dynamic forms that are regulated in complex
spatio-temporal ways by a large number of associated proteins.
Interpretation of any single CHI interaction will need to take into
account these complexities. One thing that is clear is that CHI
screens, like synthetic lethal screens, identify groups of functionally
related genes and, with respect to actin, we can conclude that
some very important cellular processes are hyper-sensitive to
reductions in actin expression.
Since actin itself is haploinsufficient, we may have expected our
screen to be overwhelmingly biased toward other genes that also
display simple haploinsufficiency. However, this does not appear
to be the case, thus bolstering the argument that, like other genetic
interactions, a CHI interaction reflects functional specificity.
Another possible explanation for CHI interactions could be
cumulative reduced biosynthetic capacity [34], but our original
CHI screen against the non-essential genes was not overly
enriched for genes involved in biosynthesis, with the exception
of the ribosome. The CHI screen against the essential genes
presented here did identify a number of genes whose products are
components of the proteasome and the core transcriptional
apparatus, but we could not detect significant changes in the
levels of actin, or the actin binding proteins Aip1p and cofilin in
strains hemizygous for RPN5, RPB3, RPC10, TAF5,o rRPS5 (data
not shown) suggesting these interactions may reflect true functional
connections.
A common interpretation of synthetic lethal interactions
between null alleles is that the two genes operate in parallel
pathways that impinge upon an essential function [4]. A
fundamental difference of a CHI interaction is that since activity
from both genes is reduced by at most 50% and not 100%, the
pathways the genes function in are not blocked entirely.
Therefore, we might expect that a CHI interaction may frequently
be indicative that the two genes/gene products function within the
same pathway or structure; that pathway function is compromised
by loss of flux due to constrictions at two steps. Given the striking
enrichment for proteasome genes and the novelty of a proteasome-
actin connection, we chose to investigate a potential functional
connection between the actin cytoskeleton and the proteasome.
Analysis of Ts
2 proteasome mutants showed that many, but not
all, have severe defects in actin organization. In some cases these
defects are so severe that this aspect of the phenotype alone might
be expected to cause cell death. The data suggest, from two
perspectives that the actin phenotypes cannot be purely explained
by losses in proteasome proteolytic activity. First, treatment of
sensitized cells with the proteasome proteolytic activity inhibitor
MG132 resulted in very distinct defects in cell polarity and actin
polarization that differs from that observed in Ts
2 proteasome
mutants. Second, several Ts
2 proteasome mutants that cease
growth entirely at 37uC arrest without any actin organization
defects. We hypothesize that the phenotypic diversity observed in
the proteasome mutants likely reflects differential effects of the
alleles on multiple proteasome activities. For example, loss of
proteolytic activity may indirectly affect actin and cell polarity.
However, we hypothesize there is a second function that is evident
when there are defects in a direct interaction between actin and
proteasomes.
This hypothesis is supported by actin filament pelleting assays
suggesting a direct physical interaction between the proteasome
and actin filaments, although we cannot rule out possible non-
specific interactions between two very large complexes. However,
we failed to see pelleting of a BSA control with actin filaments
indicating that actin is not merely ‘‘sticky’’ under these assay
conditions (data not shown). Nonetheless, the data suggest that
there are F-actin binding sites on both the 19S RP and the 20S
CP. However, since mass-spectrometry identified 19S proteins in
the 20S preparations, we cannot preclude the possibility that the
19S RP was bridging an interaction between F-actin and the 20S
core in our assays. In either case, either double-capped 26S
proteasome, or the 20S CP could be a bivalent actin filament
cross-linking protein. This model agrees well with EM images
showing a strikingly ladder-like cross-linking of rabbit muscle actin
filaments by rabbit reticulocyte proteasomes [35]. These data
suggest that the actin-proteasome interaction is conserved, which
is supported by co-localization of proteasomes with the actin
cytoskeleton in many different cell types including Xenopus oocytes
[36], epithelial cells and fibroblasts [35,37], myoblasts [38], and in
the sarcomeres of muscle cells [37,39–40].
One curious aspect of our proteasome data is that not all
proteasome genes are CHI with actin and not all Ts
2 alleles in
proteasome genes cause actin organization defects. In our previous
work on CHI interactions between actin and the non-essential
gene knock-outs [7], we uncovered functional divergence between
ribosomal paralog genes for actin-related defects. It has been
shown that proteasomes with an alternative composition can be
assembled in certain genetic backgrounds [41]. However, we do
not believe that our data suggest the existence of a proteasome of
alternative composition that has actin-specific functions. Instead,
given that proteasome assembly has been shown to occur in a
series of ordered steps [26,42], we hypothesize that subunit
limitation in hemizygous strains or mutation of certain proteasome
subunits leads to the accumulation of assembly intermediates that
selectively affect actin-specific functions of the proteasome. In
regards to the phenotypic differences between Ts
2 mutants of
proteasome component genes, this likely reflects differences in the
defects caused by the alleles. For example, some Ts
2 mutants may
affect function without affecting structure while others may affect
both function and structure. Given our results with MG132 and
actin organization, we hypothesize that proteasome structure is
required for proper actin organization but catalytic activity may
not be required for proper actin organization.
In summary, our results clearly prove the utility of CHI
screening for making novel connections between cellular subsys-
tems, for predicting gene function, and for mapping the landscape
of binary gene interactions that are likely to be relevant to system
collapse in more complex organisms including multigenic
influences in human genetic disorders. In particular, extensive
CHI interactions between actin and proteasome genes predicted a
novel role for the proteasome in affecting actin cytoskeleton
organization.
Materials and Methods
Complex haploinsufficiency screens
Complex haploinsufficiency screening was carried out as described
previously [7], with the following changes: the EuroScarf (http://
web.uni-frankfurt.de/fb15/mikro/euroscarf/) collection of heterozy-
gous diploid strains carrying essential gene deletions was first pinned
in 384-colony format to four YPD+G418 plates, incubated for two
days at 25–30u, then transferred to sporulation plates. After 7–12 days
at 25u, sporulation of randomly selected strains was confirmed
(sporulation frequencies were generally between 1–5%) and these
sporulated strains were mated on YPD to the act1D query strain
Complex Haploinsufficiency Screening with Actin
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plasmid. Subsequent steps of diploid selection and CHI analysis were
as described [7]. For some screens, the 384-colony plates were
converted to 1536-colony format, equivalent to four-fold coverage
per plate. Hand retesting was also as described previously, but with
the additional step of firstsporulating the heterozygous diploid strains
prior to mating to BHY336.
Growth curve analysis
For TECAN (Infinite F200)-based growth curves of CHI
interacting strains, we picked colonies directly from diploid
selection plates into liquid SC
msg+G418+Nat+/2FOA and
followed growth at 30u for ,48 hours. Data were imported into
Microsoft Excel for analysis and generation of growth curves. For
TECAN (Infinite F200)-based growth curves of proteasome
mutants strains, 25uC cultures in YPD medium at ,2610
7
cells/ml were placed into wells of microtiter dishes and shifted to
37uC in the TECAN incubator/reader and cell density was
monitored for 24 hr.
F-actin staining
Rhodamine-phalloidin staining of actin was as described
previously [43]. For rhodamine-phalloidin staining of complex
hemizygotes, the haploid act1D query covered with the URA3-
marked ACT1
wt plasmid was mated to sporulations of the essential
heterozygous diploid strains, the double hemizygotes were selected
on medium containing NAT and G418, and plasmid loss was
subsequently selected on 5-FOA medium. The resulting double
hemizygotes were grown to mid-log in YDP medium and stained
with rhodamine-phalloidin.
MG132 treatments
Yeast strains were grown to mid-log phase (,2610
7 cells/ml)
and MG132 (A.G. Scientific Inc, San Diego, CA) dissolved in
DMSO at 50 mM was added to a final concentration of 100 mM;
an equal volume of DMSO was added to control cultures. The
cells were incubated for 2 hr at 30uC, fixed in formaldehyde, and
stained with rhodamine-phalloidin (see above).
Detection of ubiquitinated proteins
Strains BY4742, erg6D and pdr5D were grown to mid log phase
at 30uC and then treated with 50 mM MG132 (diluted from a
50 mM stock solution in DMSO) for 2 hours. 9 ml samples were
harvested at time 0 min (before MG132 addition) and 30 min,
75 min and 120 min after MG132 addition. The cells were
pelleted, the pellets were flash-frozen on dry ice and stored at
Table 1. Strains used in this study.
Strain Genotype Source
BHY336 MATa, his3D1, leu2D0, ura3D0, mfa1D::PMFA1-Sp_his5
+ [pKFW29] [7]
TSQ1340 MATa, pre5-ph::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D [27]
TSQ1349 MATa, pup3-ph::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D [27]
TSQ1350 MATa, pre6-ph::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D [27]
TSQ1354 MATa, pre8-ph::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D [27]
TSQ1355 MATa, pre4-ph::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D [27]
TSQ1371 MATa, pup2-ph::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D [27]
TSQ255 MATa, rpn1-821::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSA255 MATa, rpn1-821::Kan
R, his3D1, leu2D0, ura3D0, met15D0 C. Boone
TSQ260 MATa, rpt4-150::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ785 MATa, rpt3-1::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ910 MATa, rpt6-20::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ1090 MATa, rpt1-1::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ1207 MATa, rpt6-1::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ1263 MATa, rpt4-145::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ405 MATa, rpn12-1::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ521 MATa, rpn11-8::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ534 MATa, rpn11-14::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ1037 MATa, rpn6-1::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
TSQ1235 MATa, rpn5-1::Nat
R, can1D::STE2
pr-Sp_his5, lyp1D::STE3
pr-LEU2 C. Boone
RJD1144 MATa, his3D200, leu2-3, 112, lys2-801, trp1D63, ura3-52, PRE1
FH:: URA3, pre1D [33]
RJD1171 MATa, his3D200, leu2-3, 112, lys2-801, trp1D63, ura3-52, RPT1
FH:: URA3, rpt1D [33]
BY4742 MATa, his3D1,leu2D0, ura3D0, lys2D0 EuroScarf
erg6D MATa, his3D1,leu2D0, ura3D0, met15D0, erg6D0::G418
r EuroScarf
pdr5D MATa, his3D1,leu2D0, ura3D0, met15D0, pdr5D0::G418
r EuroScarf
GAC201 MATa, his3-11, leu2-3,112, ura3-52, lys2-801, trp1-1, pdr5D::KanMX6, pre3D2::HIS3, pup1D::leu2-HIS3,
[pRS317-PUP1], [YCplac-PRE3], gal
2
[33]
GAC202 MATa, his3-11, leu2-3,112, ura3-52, lys2-801, trp1-1, pdr5D::KanMX6, pre3D2::HIS3, pup1D::leu2-HIS3,
[pRS317-pup1
T30A], [YCplac-pre3
T20A], gal
2
[33]
doi:10.1371/journal.pgen.1002288.t001
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50 mM Tris-HCl, pH 7.4) supplemented with 1 mM PMSF
(phenylmethanesulfonylfluoride) plus a 1:250 dilution of Calbio-
chem Protease Inhibitor Cocktail IV (Calbiochem, La Jolla, CA)
and lysed by vortexing with glass beads at 4uC. The protein
concentrations of the cell lysates were determined by Bradford
assay. The samples were diluted in an equal volume of urea-
supplemented 26sample buffer (50 mM Tris-HCl, pH 6.8, 8 M
urea, 5% SDS, 1 mM EDTA, plus a 1:20 dilution of a 1%
bromophenol blue stock and a 1:20 dilution of b-mercaptethanol),
heated to 95uC for 5 min and ,45 mg of total protein per well
were separated by SDS-PAGE followed by transfer to nitrocellu-
lose. Poly-ubiquitinated species were detected by Western blotting
with anti-ubiquitin antibody clone Ubi-1 (Millipore, Billerica, MA)
diluted 1:500 in TBST (TBS plus 0.05% Tween 20) plus 5%
dehydrated milk, followed by incubation in a secondary, HRP-
conjugated goat anti-mouse IgG antibody (Sigma-Aldrich, St.
Louis, MO) diluted 1:1000 in TBST plus milk and detection with
Supersignal (Thermo Scientific, Rockford, IL).
Actin purification
Yeast actin was purified by a modified [44] DNaseI affinity
purification procedure [45]. Briefly, 100 mg DNaseI (Roche
Diagnostics, Indianapolis, IN) was coupled to 3 g of swelled
Sepharose 4B (Sigma-Aldrich, St. Louis, MO). The coupled beads
were packed into two disposable polypropylene columns of 5 ml
maximum capacity (PIERCE/ThermoScientific, Rockford, IL).
Each column was washed with 25 ml 0.2 M NH4Cl in G-buffer
(10 mM Tris, pH 7.5, 0.2 mM CaCl2, 0.5 mM ATP and 0.2 mM
DTT) followed by 25 ml G-buffer with 0.1 mM phenylmethyl-
sulfonyl fluoride (PMSF). ,100 g of yeast pellet (Red Star Yeast
from an ,400 g brick) were thawed in ,100 ml G-buffer with
0.1 mM PMSF plus Calbiochem protease inhibitor cocktail IV
diluted 1:500. The cells were passed 8 times through a micro-
fluidizer (Microfluidics, Model 110 L, Newton, MA). The lysate
was clarified in a Beckman JA-20 rotor at 12,000 rpm for 30 min
at 4uC and then in a Beckman Ti70 rotor at 50,000 rpm for
50 min at 4uC, followed by filtration through common coffee
filters. The filtered supernatant was split between the two columns
and loaded at a flow rate of 1–2 ml/min. Each column was
washed with 25 ml of 10% deionized formamide in G-buffer,
25 ml of 0.2 M NH4Cl in G-buffer and 25 ml of G-buffer. The
actin was eluted with 50% deionized formamide in G-buffer. The
protein was dialyzed overnight in dialysis tubing (diameter
11.5 mm) with a molecular weight cut-off of 3,500 Da (Spectrum
Laboratories, Rancho Dominiguez, CA) against 2 liters of G-
buffer (25 mM ATP). The actin was further purified by FPLC on a
1 ml MonoQ column (Pharmacia Biotech, Piscataway NJ), washed
with 10 ml of G-buffer at a flow rate of 0.5 ml/min, and then
eluted with a linear, 0–300 mM KCl gradient in G-buffer. The
actin eluted above 200 mM KCl; peak fractions (as estimated by
the chromatograph and verified by SDS-PAGE gel) were pooled,
distributed in 11634 mm Beckman ultracentrifuge tubes (1 ml
per tube) and polymerized in F-buffer (G-buffer+ATP to
1m M +1 mM EGTA+4 mM MgCl2) for 20 min at room
temperature. The KCl concentration was then brought up to
600 mM and the samples were incubated for 1 h at room
temperature. Polymerized actin was pelleted by ultracentrifugation
in a Beckman TLA100.2 rotor at 90,000 rpm for 30 min. Pellets
were re-suspended in G-buffer to 1–2 mg/ml (as estimated by
PAGE), incubated on ice for 2–4 hours and dialyzed overnight in
1 liter G-buffer. Protein concentration was determined by
Bradford assay.
Purification of yeast 19S and 20S proteasome
components
Yeast 20S core proteasomal subunits were purified by an affinity
purification procedure [33] as follows. ,10 liters of strain
RJD1144 [33] expressing flag-tagged Pre1p were grown overnight
in synthetic medium, harvested, resuspended in 1 pellet volume
Table 2. The actin phenotypes of conditional proteasome mutants.
Complex Gene Allele CHI with actin Plate Growth Liquid Growth Actin phenotype
Lid RPN5 rpn5-1 yes No growth at 37u Ts
2 severe
RPN6 rpn6-1 yes No growth at 37u Ts
+ wild type
RPN11 rpn11-8 yes No growth at 37u Ts
2 severe
rpn11-14 No growth at 37u Ts
2 severe
RPN12 rpn12-1 yes No growth at 37u Ts
2 severe
Base RPN1 rpn1-821 no No growth at 37u Ts
2 wild type
RPT1 rpt1-1 no Slow growth at 37u Ts
2 wild type
RPT3 rpt3-1 no No growth at 37u Ts
+ wild type
RPT4 rpt4-145 no No growth at 37u Ts
2 moderate
rpt4-150 Slow growth at 37u Ts
2 moderate
RPT6 rpt6-1 no No growth at 37u Ts
+ wild type
rpt6-20 No growth at 37u Ts
+ wild type
a ring PRE5 pre5-ph yes Slightly slow growth at 37u Ts
+ wild type
PRE6 pre6-ph no Slow growth at 25u and 37u Ts
+ wild type
PRE8 pre8-ph no Slow growth at 37u Ts
+ severe
PUP2 pup2-ph no Slow growth at 37u Ts
+ moderate
b ring PRE4 pre4-ph no No growth at 37u Ts
+ wild type
PUP3 pup3-ph no Slightly slow growth at 37u Ts
+ wild type
doi:10.1371/journal.pgen.1002288.t002
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and frozen at 220uC. The cells were thawed in a room
temperature water bath and then passed through a microfluidizer
(Microfluidics, Model 110 L, Newton, MA) 10 times. The lysate
was clarified in a Beckman JA-20 rotor at 17,000 rpm for 20 min
and loaded onto a column packed with 1 ml anti-Flag M2 agarose
beads (Sigma, St. Louis, MO). The column was washed with
50 ml lysis buffer+0.2% Triton, followed by two 50 ml washes
with lysis buffer. The protein was eluted with elution buffer
[25 mM Tris, pH 7.5, 150 mM NaCl, 50 mM MgCl2, 100 mg/ml
FLAG peptide (Sigma, St. Louis, MO)], four 3 ml elutions were
collected, the column was washed three times with 3 ml elution
buffer minus the peptide and these fractions were collected as well.
Protein concentrations were measured by Bradford assay, the
fractions were pooled and the sample was dialyzed in dialysis
tubing (diameter 11.5 mm) with a molecular weight cut-off of
3,500 Da (Spectrum Laboratories, Rancho Dominiguez, CA)
against 1 liter G-buffer. The sample was then concentrated in a
Vivaspin 15R concentrator (Sartorius Stedim Biotech, Bohemia,
NY) and protein concentration was measured by Bradford assay.
For purification of the 19S proteasomal cap the same procedure
was followed using strain RJD1171 (Table 1, [33]), which
expresses flag-tagged Rpt1p.
F-actin pelleting assays
To evaluate F-actin-proteasome interactions, 4 mM yeast actin
was left for 1 h at room temperature to reach equilibrium in G-
(5 mM HEPES, pH 7.5, 0.2 mM CaCl2, 0.2 mM ATP, 0.5 mM
DTT) or F-buffer (27.5 mM HEPES, pH 7.5, 0.2 mM CaCl2,
25 mM KCl, 1 mM EGTA, 4 mM MgCl2, 0.7 mM ATP,
0.5 mM DTT) in the presence of either ,65 nM 19S regulatory
particle or 50–100 nM 20S core particle in 125 ml total volume.
The reactions were submitted to high-speed centrifugation
(70,000 rpm for 30 min in a TL100 ultracentrifuge), followed by
SDS-PAGE and SYPRO Ruby (Bio-Rad, Hercules CA) staining
of the total reaction (T), supernatant (S) and pellet (P). Note that
the supernatant fractions were taken from the top of the
centrifugation reactions.
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